Biotechnology News TRELSTAR Search

BioNews
Biotechnology, Pharmaceutical, Life Science & Medical News
Track this topic with BioWatch News Alerts: Register | Login

Search Results

Documents 1-5 out of 5 found

Current Search: trelstar: 5

Watson Pharmaceuticals Inc - Corporate and Strategic Assessment Report - Company Strategy, SWOT Analysis -
www.companiesandmarkets.com/Summary-Company-Profile/Watson-Pharm ..

Introduction Watson Pharmaceuticals (Watson) is the third largest generic pharmaceutical company in the US.

The company develops, manufactures, markets and distributes...

PR inside: Jul 17 2008 7:28AM
Matching: trelstar

Find similar documents

West MixJect System Selected By Watson For Use In Treatment Of Prostate Cancer
West, the world's premier manufacturer of components and systems for injectable drug delivery, announced that Watson Pharma, Inc., a subsidiary of Watson Pharmaceuticals, Inc., has selected MixJect as the new delivery system for TRELSTAR...

Pharmaceutical Online: Jul 16 2008 1:43PM
Matching: trelstar

Find similar documents

Watson announces approval of new drug delivery system
Mixject, developed and manufactured by Medimop Medical Projects, a subsidiary of West Pharmaceutical Services, is said to combine the proven efficacy of Trelstar Depot 3.75mg and Trelstar LA 11.25mg with new features that make...

Pharmaceutical Business Review: May 3 2008 5:17AM
Matching: trelstar

Find similar documents

FDA Approves Mixject, a Convenient, Easy-to-Use Drug Delivery System For Watson Pharmaceutical's Trelstar Depo
/PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc.

, a leading specialty pharmaceutical company, announced today that the U.S.

Food and Drug Administration has approved MIXJECT(TM), the new delivery system for TRELSTAR(R) ...

Pharma Live: Apr 30 2008 2:29PM
Matching: trelstar

Find similar documents

FDA Approves MIXJECT(TM), a Convenient, Easy-to-Use Drug Delivery System For Watson Pharmaceutical's TRELSTAR(
CORONA, Calif., April 30 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc.

, a leading specialty pharmaceutical company, announced today that the U.S.

Food and Drug Administration has approved MIXJECT(TM), the new delivery system...

Stockwatch: Apr 30 2008 1:16PM
Matching: trelstar

Find similar documents

Home Marketing Services News Reports Company Profiles InDepth Drug Discovery Careers Conferences Videos Search Contact
	Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner. See User Agreement Send comments and feedback to: Peter Barfoot Managing Director, BioPortfolio Ltd. UK Tel: (+44) 1300 321501 USA Voicemail and Fax: (+1) 415 680 2472	All rights reserved. All other trademarks recognized. BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10 Copyright � 1997-2008 - BioPortfolio Limited.